Volume 4,Issue 2
Objective: To investigate the preventive effects of early pregnancy preeclampsia screening combined with personalized intervention on gestational diseases and adverse pregnancy outcomes in obese pregnant women. Methods: A retrospective analysis was conducted on the differences in clinical intervention effects among 67 obese pregnant women in early pregnancy (from June 2023 to February 2025). All subjects underwent early pregnancy preeclampsia screening and were subsequently grouped based on differences in gestational health intervention plans. The clinical effects of conventional intervention (control group, 33 cases) and personalized intervention (study group, 34 cases) were compared. Results: Compared with the control group, the SQHMP score increased in the study group after intervention, and the weight gain at 20 weeks of gestation and before delivery decreased (P < 0.05). Compared with the control group, the study group had a higher rate of normal delivery and lower incidences of gestational diseases and adverse pregnancy outcomes after intervention (P < 0.05). Conclusion: Personalized intervention during pregnancy for obese pregnant women based on the results of early pregnancy preeclampsia screening can maintain healthy weight gain during pregnancy, assist in developing self-management skills during pregnancy, and reduce the risk of gestational diseases and adverse pregnancy outcomes.